New Controversy for 340B: OPA Rebuffs Ruling by Court.
نویسنده
چکیده
In a new 340B controversy, OPA rebuffs a court ruling.
منابع مشابه
Hospital Group Wants to Expand Section 340B Drug Purchase Program.
the House Ways and Means Committee on September 23. He explained that this would allow the hospitals to further stretch their limited resources and relieve them of the burden of carrying two separate inventories and pricing structures for inpatient and outpatient drugs. Theoretically, the Ways and Means Committee, in conjunction with Energy and Commerce and Senate Finance, could initiate author...
متن کاملHealth Care Reform Bill Expands Access to Section 340B Discounted Drugs for Hospitals.
ally 25% to 40% of the average manufacturer’s price (AMP). That differential goes into the hospital’s pocket, totaling as much as $10 million per year for some larger hospital systems. That dab of honey on the bottom line of a safety net hospital (or federal clinic) is especially sweet these days, with public hospitals beset by state cutbacks in Medicaid funding at the same time that their unco...
متن کاملCattanach v Melchior and Implications for Health Information Managers.
The recent High Court ruling upholding a prior decision to allow a mother to sue for the cost of rearing a child after having had a failed sterilisation has understandably attracted great controversy (Cattanach v Melchior [2003]). The implications of this decision on what can now be claimed for through medical litigation are significant, and lawyers and doctors will extract from it lessons for ...
متن کاملConstitutional Law: Abstention Doctrine Applied to Avoid Decision on Constitutionality of Closing Public Schools
SINCE its initial formulation by the Supreme Court in 1941,1 the doctrine of equitable abstention has been a subject of continuing controversy.2 Its application in the field of civil rights by a sharply divided Supreme Court in 19593 raised many questions, several of which are illustrated by Griffin v. Board of Supervisors. 4 In this latest decision in twelve years of litigation aimed at the in...
متن کاملGenerics still unable to resolve ANDA patent issues by declaratory judgment, but is a supreme court resolution on the way?
The Supreme Court recently denied certiorari to review the Federal Circuit’s ruling in Apotex v. Pfizer (S. Ct. 906-1006, October 16, 2006). The ruling was predictable. Pfizer had mooted the case by providing a covenant not to sue Apotex on its Quinapril patent. But the underlying legal issue – subject matter jurisdiction in declaratory judgment cases – is currently pending before the Supreme C...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 39 9 شماره
صفحات -
تاریخ انتشار 2014